• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION; SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION; SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE Back to Search Results
Device Problems Contamination (1120); Improper or Incorrect Procedure or Method (2017)
Patient Problems Abdominal Pain (1685); Peritonitis (2252)
Event Date 09/21/2015
Event Type  Injury  
Manufacturer Narrative
(b)(4).This report is for a breach in aseptic technique which resulted in peritonitis.Per baxter labeling, users are instructed to use aseptic technique when performing peritoneal dialysis therapy.A review of the label for the product family will be conducted.Should additional relevant information become available, a supplemental report will be submitted.
 
Event Description
It was reported that a patient experienced a breach in aseptic technique which resulted in peritonitis coincident with peritoneal dialysis therapy.There was no further description of the breach in aseptic technique.Peritonitis was manifested by abdominal pain.On the day of onset, the patient was hospitalized for the peritonitis event.Beginning on the day of onset, the patient was treated with unspecified antibiotics (route, medication, dosage, frequency, and duration not reported) for the peritonitis event.Antibiotic treatment was ongoing.The care plan was to treat the patient with intraperitoneal vancomycin (dosage, frequency, and duration not reported) upon hospital discharge for the peritonitis event.On an unreported date, dianeal therapies were discontinued and the patient was switched to hemodialysis therapy, but the care plan was to return the patient to peritoneal dialysis therapy upon discharge from the hospital.Hospitalization was ongoing.The patient was recovering from the peritonitis event.It was not reported if the patient was retrained on the proper aseptic technique.No additional information is available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Type of Device
SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
Manufacturer (Section G)
BAXTER HEALTHCARE CORPORATION
Manufacturer Contact
kinga almasan
25212 w. illinois route 120
round lake, IL 60073
2242702068
MDR Report Key5150828
MDR Text Key28293936
Report Number1416980-2015-38975
Device Sequence Number1
Product Code KDJ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Nurse
Report Date 10/14/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received10/14/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
DIANEAL 2.5% AND 4.25% LOW CALCIUM ULTRABAG
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age59 YR
-
-